Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy

American Heart Journal

Volumn 156, Issue 3, 2008, Pages 422-430

  Bestetti, Reinaldo B ^a   Theodoropoulos, Tatiana A D ^a   Cardinalli Neto, Augusto ^a   Cury, Patrícia M ^b  

^a Outpatient Cardiomyopathy Service

^b HOSPITAL DE BASE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; AMIODARONE; BENZNIDAZOLE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; LANATOSIDE; MAGNESIUM; METILDIGOXIN; METOPROLOL; NORADRENALIN; SPIRONOLACTONE;

ANTICOAGULANT THERAPY; CATECHOLAMINE URINE LEVEL; CHAGAS DISEASE; DEFIBRILLATION; DISEASE COURSE; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HEMODYNAMICS; HOLTER MONITORING; HUMAN; MAGNESIUM BLOOD LEVEL; PATHOLOGY; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SECONDARY PREVENTION; SODIUM RESTRICTION; SUDDEN DEATH; SYSTOLIC HEART FAILURE; TRYPANOSOMA CRUZI;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOLOGY; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DISEASE PROGRESSION; DIURETICS; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; SYSTOLE;

EID: 49949095970     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.04.023     Document Type: Review

References (51)

1. UNICEF-UNDP-World Bank-World Health Organization Special Programme for Research and Training in Tropical Diseases. Available at www.who.int/tdr/diseases/Chagas [Last accessed on September 11, 2007].
2. Chagas' disease-an epidemic that can no longer be ignored. Lancet 368 (2006) 619
3. Laranja F.S., Dias E., Nóbrega G., et al. Chagas' disease. A clinical, epidemiologic, and pathologic study. Circulation 14 (1956) 1035-1060
4. Oliveira J.S.M., Araujo R.C., Navarro M.A., et al. Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. Am J Cardiol 52 (1983) 147-151
5. Bestetti R.B., Ariolli M.T., Carmo J.L., et al. Clinical characteristics of acute myocardial infarction in patients with Chagas' disease. Int J Cardiol 35 (1992) 371-376
6. Bestetti R.B., and Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol 60 (1997) 187-193
7. Coura J.R., and Pereira J.B. A follow up evaluation of Chagas' disease in two endemic areas in Brazil. Mem Inst Oswaldo Cruz 79 Suppl 1 (1984) 107-112
8. Acquatella H., Catalioti F., Mancero J.G., et al. Long-term control of Chagas' disease in Venezuela: effects of serologic findings, electrocardiographic abnormalities, and clinical outcome. Circulation 76 (1987) 556-562
9. Rassi Jr. A., Rassi A., Little W.C., et al. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 355 (2006) 799-808
10. Bestetti R.B., Dalbo C.M.R., Arruda C.A., et al. Predictors of sudden cardiac death for patients with Chagas' disease: a hospital-derived cohort study. Cardiology 87 (1996) 481-487
11. Espinosa R., Carrasco H.A., Belandria F., et al. Life expectancy analysis in patients with Chagas' disease: prognosis after one decade (1973-1983). Int J Cardiol 8 (1985) 45-56
12. Bestetti R.B., and Rossi M.A. A rationale approach for mortality risk stratification in Chagas' heart disease. Int J Cardiol 58 (1997) 199-209
13. Bellabarba G., Davila D.H., Torres A., et al. A Serum renin activity in chagasic patients with and without congestive heart failure. Int J Cardiol 47 (1994) 5-11
14. Davila D.F., Bellabarba G., Hernandez L., et al. Serum norepinephrine, myocardial damage, and left ventricular systolic function in Chagas' heart disease. Int J Cardiol 52 (1995) 145-151
15. Bestetti R.B., Coutinho-Neto J., Staibano L., et al. Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas' disease. Cardiology 86 (1995) 202-206
16. Kaye D.M., Lefkovitz J., Cox H., et al. Regional epinephrine kinetics in human heart failure: evidence for extra-adrenal, nonneural release. Am J Physiol 269 (1995) H182-H188
17. Bestetti R.B., Ramos C.P., Figueredo-Silva J., et al. Ability of the electrocardiogram to detect myocardial lesions in isoproterenol-induced rat cardiomyopathy. Cardiovasc Res 21 (1987) 916-921
18. Acquatella H. Echocardiography in Chagas' heart disease. Circulation 115 (2007) 1124-1131
19. Espinosa R.A., Pericchi L.R., Carrasco H.A., et al. Prognostic indicators of chronic chagasic cardiopathy. Int J Cardiol 30 (1991) 195-202
20. Mady C., Cardoso R.H., Barreto A.C.P., et al. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 90 (1994) 3098-3102
21. Theodoropoulos T.A.D., Bestetti R.B., Otaviano A.P., et al. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy. Int J Cardiol 128 (2008) 22-29
22. Câmara E.J.N., Cruz T.R.P., Nassri J.M., et al. Muscle magnesium content and cardiac arrhythmias during treatment of congestive heart failure due to chronic chagasic cardiomyopathy. Braz J Med Biol Res 19 (1986) 49-58
23. Braga J.C.V., Reis F., Aras R., et al. Aspectos clínicos e terapêuticos da Insuficiência Cardíaca por doença de Chagas. Arq Bras Cardiol 86 (2006) 297-302
24. Roberti R.R., Martinez E.E., Andrade J.L., et al. Chagas' cardiomyopathy and captopril. Eur Heart J 13 (1992) 966-970
25. Szajnbock F.E.K., Barretto A.C.P., Mady C., et al. Ação benéfica do enalapril sobre a função diastólica ventricular na Miocardiopatia da doença de Chagas. Arq Bras Cardiol 60 (1993) 273-278
26. Botoni F.A., Poole-Wilson P.A., Ribeiro A.L.P., et al. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas' cardiomyopathy. Am Heart J 153 (2007) 544-548
27. Bestetti R.B., Sales-Neto V.N., Pinto L.Z., et al. Effects of long term metoprolol administration on the electrocardiogram of rats infected with T. cruzi. Cardiovasc Res 24 (1990) 521-525
28. Davila D.F., Angel F., Bellabarba G.A., et al. Effects of metoprolol in chagasic patients with severe congestive heart failure. Int J Cardiol 85 (2002) 255-260
29. Merit-HF Study group. Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
30. Willenheimer R., van Veldhuisen D.J., Silke B., et al. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril as compared with the opposite sequence. Circulation 112 (2005) 2426-2435
31. Network investigators. Clinical outcome with enalapril in symptomatic chronic heart failure: a dose comparison study. Eur Heart J 19 (1998) 481-489
32. Packer M., Poole-Wilson P.A., Armstrong P.W., et al. Comparative effects of low and high doses of the angiotensin converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS study group. Circulation 100 (1999) 3212-3218
33. Manço J.C., Gallo Jr. L., Godoy R.A., et al. Efeitos hemodinâmicos do digital na Cardiopatia Chagásica Crônica. Arq Bras Cardiol 27 (1974) 25-35
34. Khoury A.M., Davila D.F., Bellabarba G., et al. Acute effects of digitalis and enalapril on the neurohormonal profile of chagasic patients with severe congestive heart failure. Int J Cardiol 57 (1996) 21-29
35. Barretto A.C.P., and Pileggi F.J.C. Digital na cardiopatia chagásica. Arq Bras Cardiol 38 (1982) 283-289
36. Bestetti R. Stroke in a hospital-derived cohort of patients with chronic Chagas' heart disease. Acta Cardiol 55 (2000) 33-38
37. Carod-Artal F.J., Vargas A.P., Horan T.A., et al. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas' disease. Stroke 36 (2005) 965-970
38. Viotti R., Vigliano C., Lococo B., et al. Long-term outcomes of treating chronic Chagas' disease with benznidazole versus no treatment. Arch Int Med 144 (2006) 724-734
39. Sandercock G.R.H., and Brodie D.A. The role of heart rate variability in prognosis for different modes of death in chronic heart failure. Pac Clin Electrophysiol 29 (2006) 892-904
40. Rassi Jr. A., Rassi A.G., Rassi S.G., et al. Arritmias ventriculares na doença de Chagas. Particularidades diagnósticas, prognósticas e terapêuticas. Arq Bras Cardiol 65 (1995) 377-387
41. Silva R.M.F.L., Távora M.Z.P., Gondim F.A.A., et al. Predictive value of clinical and electrophysiological variables in patients with chronic chagasic cardiomyopathy and non-sustained ventricular tachycardia. Arq Bras Cardiol 75 (2000) 41-47
42. Cardinalli-Neto A., Greco O.T., and Bestetti R.B. Automatic implantable cardioverter-defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias. Pacing Clin Electrophysiol 29 (2006) 467-470
43. Bardy G., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
44. Bestetti R.B., Santos C.R.F., Machado Jr. O.B., et al. Clinical profile of patients with Chagas' disease before and during ventricular tachycardia. Int J Cardiol 29 (1990) 39-46
45. Cardinalli-Neto, Bestetti R.B., Cordeiro J.A., et al. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol 18 (2007) 1236-1240
46. Leite L.R., Fenelon G., Simões Jr. A., et al. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. J Cardiovasc Electrophysiol 14 (2003) 567-573
47. Bestetti R.B., Souza T.S., Lima M.F., et al. Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas' heart transplant recipients. Transplantation 84 (2007) 441-442
48. Bocchi E.A., and Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. Ann Thorac Surg 71 (2001) 1833-1838
49. Vilas-Boas F., Feitosa G.A., Soares M.B.P., et al. Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas' disease. Arq Bras Cardiol 87 (2006) 159-166
50. Talvani A., Rocha M.O.C., Cogan J., et al. Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy. Mem Inst Oswaldo Cruz 99 (2004) 645-649
51. Bestetti R.B. Predictors of unfavourable prognosis in chronic Chagas' disease. Trop Med Int Health 6 (2001) 476-483